Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Apr 15, 2026

EUFN ETF Climbs +11% in 30 Days: Unpacking the Rally in European Financials

Key Takeaways

  • EUFN surged +11% over the past 30 days, driven by a strong rebound in European bank stocks amid solid earnings and stabilizing interest rates.
  • Over the past quarter, the ETF gained +3%, reflecting resilience despite geopolitical tensions impacting markets earlier in the period.
  • Top holdings like HSBC Holdings (9.2% weight) and Banco Santander (5.3%) led gains, supported by higher net interest margins (NIM) for banks in a high-rate environment.
  • Banks (57% allocation) and insurance (24%) sectors outperformed, buoyed by positive earnings surprises from European lenders.
  • Macro factors including ECB policy stability and robust trading income contributed to the ETF's upward momentum.

Understanding EUFN: Portfolio Overview and Sector Exposure

The iShares MSCI Europe Financials ETF (EUFN) tracks the MSCI Europe Financials Index, which measures the performance of developed market European equities in the financials sector. It holds approximately 84 securities, providing targeted exposure to banks, insurers, and other financial firms across Europe.

Key holdings include HSBC Holdings PLC (9.2%), Banco Santander SA (5.3%), and Allianz SE (5.0%), with top 10 positions comprising over 42% of assets. Sector allocation is dominated by banks at 56.7%, insurance at 24.3%, and diversified financial services at 17.8%. From what I see, this heavy tilt toward interest-rate sensitive banks explains EUFN's sensitivity to monetary policy and economic cycles, which has fueled its recent gains as European lenders benefited from elevated rates.

EUFN Price Performance: 30-Day Surge vs. Quarterly Gains

Over the last 30 days (March 16 to April 14, 2026), EUFN's price rose from $34.46 to $38.29, marking a +11% gain. The movement was volatile but trend-driven, with a dip to $34.85 on March 31 followed by a steady climb, reflecting a sharp rebound.

In the past quarter (January 15 to April 14, 2026), the ETF edged up +3% from $37.29 to $38.29. Performance was range-bound early on amid market pressures, but strengthened lately, outperforming broader European indices in the recovery phase. I also checked this using Tickeron’s AI Screener to see how EUFN compares to others in the sector.

Drivers Behind EUFN's +11% Rise in the Last 30 Days

EUFN's +11% advance stemmed primarily from robust performance in its bank-heavy portfolio. Leaders like HSBC Holdings and UniCredit gained on strong quarterly results, with European banks exceeding earnings estimates through elevated trading income and cost controls. Higher net interest margins (NIM), benefiting from sustained ECB rates, boosted profitability for holdings such as Banco Santander and BNP Paribas.

Sector performance was key, with banks (56.7% weight) rallying post a mid-March geopolitical dip tied to Middle East tensions. Macro trends like stable inflation and positive economic data supported sentiment shifts toward financials. While specific fund flows data is limited, rising AUM to $3.73 billion signals investor interest. One thing that stands out is how these factors aligned to push the ETF higher.

Quarterly Performance: What Powered EUFN's +3% Gain

The ETF's modest +3% quarterly gain reflected a mix of headwinds and tailwinds. Early pressures from regional conflicts weighed on stocks, with European banks down amid broader market declines. However, cumulative strength in major holdings like Allianz and UBS, driven by record 2025 gains extending into Q1, provided uplift.

Longer-term macro conditions, including persistent high rates enhancing NIM and excess capital at banks, outweighed volatility. Institutional interest and sector cycles favored financials, with EUFN's concentrated exposure amplifying these trends over the three months. In my view, this resilience makes it worth watching closely.

AI Screener

One tool I regularly use in my analysis is Tickeron’s AI Screener, an AI-powered stock and ETF discovery tool that helps me filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. I can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, which has been helpful for digging into ETFs like EUFN. If you're analyzing sector performance, it's worth exploring.

EUFN Outlook: Key Factors I'm Monitoring Next

Investors should monitor ECB interest rate decisions, as changes could impact bank NIM and insurance profitability. Track earnings from top holdings like HSBC and Santander for updates on loan growth and capital returns. Geopolitical developments in Europe and the Middle East remain risks to sector sentiment. Broader macro trends, including inflation data and economic growth indicators, will influence financials' appeal. Watch fund flows and AUM shifts for signs of institutional positioning in European financials. This is important because it could signal the next moves for EUFN.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: EUFN

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


EUFN's Stochastic Oscillator is sitting in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EUFN advanced for three days, in of 358 cases, the price rose further within the following month. The odds of a continued upward trend are .

EUFN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 334 cases where EUFN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for EUFN moved out of overbought territory on August 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EUFN as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for EUFN turned negative on August 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EUFN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Notable companies

The most notable companies in this group are Allergan plc (NYSE:AGN), Prudential Financial (NYSE:PRU), Archer Daniels Midland Company (NYSE:ADM), EQT Corp (NYSE:EQT), Regions Financial Corp (NYSE:RF).

Industry description

The investment seeks to track the investment results of the MSCI Europe Financials Index composed of developed market European equities in the financials sector. The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index designed to measure the combined equity market performance of the financials sector of developed market countries in Europe.

Market Cap

The average market capitalization across the iShares MSCI Europe Financials ETF ETF is 32.68B. The market cap for tickers in the group ranges from 348.67K to 213.36B. SAN holds the highest valuation in this group at 213.36B. The lowest valued company is NEXI at 348.67K.

High and low price notable news

The average weekly price growth across all stocks in the iShares MSCI Europe Financials ETF ETF was 18%. For the same ETF, the average monthly price growth was 37%, and the average quarterly price growth was 47%. EBS experienced the highest price growth at 11%, while NN experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the iShares MSCI Europe Financials ETF ETF was 25%. For the same stocks of the ETF, the average monthly volume growth was -19% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 57
Price Growth Rating: 50
SMR Rating: 61
Profit Risk Rating: 57
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
EUFN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category EuropeStock

Profile
Details
Category
Europe Stock
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.